Director Patrick J. Mahaffy filed a Form 4 with the SEC on November 17, 2026, disclosing the acquisition of 14,534 common shares of Medicus Pharma Ltd. (NASDAQ:MDCX) through a private placement transaction dated November 13, 2026.

Key Highlights

  • Shares acquired: Patrick J. Mahaffy acquired 14,534 common shares, no par value, on November 13, 2026.
  • Purchase price: Shares were purchased at $1.72 per share via a subscription agreement.
  • Transaction type: The acquisition (transaction code A) was made through a private placement in which other investors also participated under separate subscription agreements.
  • Resulting ownership: Following the transaction, Mahaffy beneficially owns 15,243 common shares directly.
  • Role: Mahaffy is identified in the filing as a Director of Medicus Pharma Ltd.

Mahaffy's Private Placement Purchase of Medicus Pharma Common Shares

According to the Form 4 filed on November 17, 2026, Patrick J. Mahaffy, a Director of Medicus Pharma Ltd., entered into a subscription agreement with the issuer on November 13, 2026. Under that agreement, Mahaffy agreed to purchase 14,534 common shares, no par value, at a purchase price of $1.72 per share. The filing notes that this was part of a private placement "in which other investors also participated under separate subscription agreements."

The filing records the transaction under Table I (Non-Derivative Securities) with transaction code "A," indicating an acquisition of shares directly. Prior to the transaction, Mahaffy held 709 common shares, and following the reported transaction, his total direct beneficial ownership stands at 15,243 common shares, as disclosed in the filing.

The Form 4 was signed by Raza Bokhari as Attorney-in-Fact for Patrick J. Mahaffy and filed with the SEC on November 17, 2026. No derivative securities transactions were reported. The filing does not indicate that the transaction was made pursuant to a Rule 10b5-1(c) plan.

What Was Disclosed

The filing discloses a single acquisition by Director Patrick J. Mahaffy of 14,534 Medicus Pharma Ltd. common shares at $1.72 per share through a private placement on November 13, 2026, bringing his total direct beneficial ownership to 15,243 shares.